PolyPeptide Group AG

    Jurisdiction
    Switzerland
    LEI
    5067007JCKTPOX4G9758
    ISIN
    CH1110760852 (PPGN.SW)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €601.35M
    Gross margin
    9.4%
    EBIT
    -€21.30M
    EBIT margin
    -3.5%
    Net income
    -€43.67M
    Net margin
    -7.3%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €345.48M -42.5% -€14.69M -66.4%
    €407.58M +18.0% -€15.11M +2.9%
    €487.68M +19.7% €13.40M -188.7%

    Dividends

    Last dividend amount
    CHF 0.30
    Ex date
    Payment date

    Add to watchlist

    Notifications